The most pressing medical concern surrounding the Leefar boom involves supplement stacking. Many buyers experimenting with viral fat burners are simultaneously managing their weight through clinical GLP-1 receptor agonists like semaglutide or tirzepatide. This combination invites severe physiological blowback.
Dietitians reporting for medical nutrition outlets have raised explicit warnings against combining over-the-counter metabolic boosters with injectable GLP-1 therapies. Because medications like semaglutide radically delay gastric emptying, taking high-stimulant compounds leads to erratic absorption rates. High doses of caffeine stay trapped in the upper digestive tract for hours, amplifying nausea, acid reflux, and persistent palpitations.
The presence of berberine introduces separate metabolic hazards. When combined with prescription medications that alter glycemic control, the additive insulin-sensitizing properties can trigger acute episodes of hypoglycemia. Symptoms include cold sweats, lightheadedness, disorientation, and sudden fainting spells. For individuals managing underlying metabolic disorders, uncontrolled stacking of unregulated powdered drink mixes presents a clear, documented health liability.
